These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16100680)

  • 1. New trends in clinical and experimental immunosuppression--fourth international conference. 17-20 February 2000, Geneva, Switzerland.
    Adorini L
    IDrugs; 2000 May; 3(5):496-8. PubMed ID: 16100680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New trends in immunosuppression.
    Cobbold SP
    Int Immunopharmacol; 2005 Jan; 5(1):1-5. PubMed ID: 15589453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimization and withdrawal of steroids in pancreas and islet transplantation.
    Mineo D; Sageshima J; Burke GW; Ricordi C
    Transpl Int; 2009 Jan; 22(1):20-37. PubMed ID: 18855850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New immunosuppressive drugs for prevention and treatment of rejection in renal transplant.
    Segoloni GP; Quaglia M
    J Nephrol; 2006; 19(5):578-86. PubMed ID: 17136684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.
    Racapé M; Vanhove B; Soulillou JP; Brouard S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):253-61. PubMed ID: 19585222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
    Chatenoud L
    Handb Exp Pharmacol; 2008; (181):221-36. PubMed ID: 18071948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.
    Merani S; Truong WW; Hancock W; Anderson CC; Shapiro AM
    Cell Transplant; 2006; 15(4):295-309. PubMed ID: 16898223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical islet transplantation at the University of Alberta--the Edmonton experience.
    Truong W; Lakey JR; Ryan EA; Shapiro AM
    Clin Transpl; 2005; ():153-72. PubMed ID: 17424733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions for induction immunosuppression strategy in solid organ transplantation.
    Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
    Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conference Scene: Autoimmunity and transplantation: basic science and clinic translation meet in Geneva. 9th International Conference on New Trends in Immunosuppression and Immunotherapy 4-6 February 2010, Geneva, Switzerland.
    Romagnani C
    Immunotherapy; 2010 Jul; 2(4):447-51. PubMed ID: 20635998
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined liver and islet transplantation using steroid-free immunosuppression.
    Popescu I; Dima S; Guja C; Gheorghe L; Iacob S; Hrehoreţ D; Matei E; Dorobanţu B; Botea F; Sârbu V; Tulbure D; Ionescu-Tîrgovişte C
    Chirurgia (Bucur); 2007; 102(5):597-602. PubMed ID: 18018363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in immunosuppression and immunotherapy.
    Jiang S; Lombardi G
    Int Immunopharmacol; 2006 Dec; 6(13-14):1874-8. PubMed ID: 17161339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells.
    Lim DG; Joe IY; Park YH; Chang SH; Wee YM; Han DJ; Kim SC
    Transpl Immunol; 2007 Nov; 18(2):94-100. PubMed ID: 18005851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pancreatic islet transplantation in humans.
    Nanji SA; Shapiro AM
    Diabetes Obes Metab; 2006 Jan; 8(1):15-25. PubMed ID: 16367878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimization of immunosuppression in kidney transplantation.
    Augustine JJ; Hricik DE
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we measure immunologic tolerance in humans?
    Najafian N; Albin MJ; Newell KA
    J Am Soc Nephrol; 2006 Oct; 17(10):2652-63. PubMed ID: 16928808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.